BAT backs German cannabis company as potential new European market beckons

British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio as part of its plan to transition to a smoke-free future.

After increasing its stake in Canada’s CBD firm Organigram in April, the tobacco giant has now entered the European cannabis market, leading a $37.6m investment round into Germany’s medical cannabis business Sanity.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*